We invite you and your physician colleagues to join in this multidisciplinary webinar featuring Dr. Jake Thiessen, who brings vast experience in bioequivalence and the implications in patient care.
Dr. Thiessen will showcase the scientific principles and evidence supporting Health Canada’s standards and testing criteria used to establish bioequivalence, a measure that applies to both generic and brand name drugs.
By attending this unique event, you will have a deeper understanding of the significant economic implications of drug selection; and be better prepared to provide your patients accurate information that is consistent throughout their circle of care.

This 1.5 hour program will include a presentation by Dr. Thiessen followed by an interactive Q&A